Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 4 1Phase 3 1

Status

Completed 3Unknown 1Terminated 1

Sponsor Class

OTHER 43INDUSTRY 5OTHER_GOV 3NIH 1

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 2Breast 1

Conditions

Neoplasms 2Malnutrition 2Neoplasm Metastasis 1Hepatitis C, Chronic 1Gastrointestinal Neoplasms 1Fibrosis 1Carcinoma, Hepatocellular 1Cachexia 1Breast Neoplasms 1Abdominal Neoplasms 1

Interventions

pembrolizumab 1023Carboplatin 964Paclitaxel 933Gemcitabine 794Cisplatin 751Docetaxel 683Bevacizumab 609Pemetrexed 502Nivolumab 487Cyclophosphamide 471Capecitabine 461Fluorouracil 418Dexamethasone 403Rituximab 372Oxaliplatin 348Injections 345atezolizumab 298Trastuzumab 298Leucovorin 288Cetuximab 282Irinotecan 268130-nm albumin-bound paclitaxel 254Prednisone 245Doxorubicin 240Ipilimumab 226Lenalidomide 220fludarabine 218Fulvestrant 217durvalumab 205Erlotinib Hydrochloride 188

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
INDUSTRY × Interventional × Dietary Supplements × Clear all
NCT07199556 2025-10-03

DOLFLEX

Arafarma Group, S.A.

Phase NA Completed
30 enrolled
Breast

Breast Neoplasms

NCT05495360 2025-02-19

OMENS

Nutricia Research

Phase NA Completed
48 enrolled

Neoplasms, Malnutrition

NCT01894828 2013-07-10

Nutritional Supplementation in Patients With no Signs of Malnutrition

MedSource Polska

Phase 4 Unknown
200 enrolled
Gastrointestinal

Abdominal Neoplasms, Gastrointestinal Neoplasms, Neoplasm Metastasis, Malnutrition

NCT00851448 2011-06-02

Safety, Tolerance and Efficacy of an Oral Nutritional Supplement in Lung Cancer Patients

Fresenius Kabi

Phase NA Terminated
17 enrolled

Cachexia, Neoplasms

NCT00502086 2011-02-11

Efficacy and Safety of Viusid in Patients With Hepatic Cirrhosis Secondary to Hepatitis C Virus Infection.

Catalysis SL

Phase 3 Completed
100 enrolled
Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular, Hepatitis C, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡